Yonggang Cao Selected Research

carvacrol

10/2019	The neuroprotective effects of carvacrol on ischemia/reperfusion-induced hippocampal neuronal impairment by ferroptosis mitigation.
12/2018	Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats.
6/2018	The transient receptor potential vanilloid-3 regulates hypoxia-mediated pulmonary artery smooth muscle cells proliferation via PI3K/AKT signaling pathway.
2/2017	Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
1/2017	The Neuroprotective Effects of Carvacrol on Ethanol-Induced Hippocampal Neurons Impairment via the Antioxidative and Antiapoptotic Pathways.
1/2016	Carvacrol induces the apoptosis of pulmonary artery smooth muscle cells under hypoxia.
9/2015	Carvacrol inhibits proliferation and induces apoptosis in human colon cancer cells.
1/2014	Carvacrol alleviates ischemia reperfusion injury by regulating the PI3K-Akt pathway in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yonggang Cao Research Topics

Disease

8	Cardiomegaly (Heart Hypertrophy) 03/2022 - 12/2018
7	Hypoxia (Hypoxemia) 01/2021 - 05/2013
6	Autistic Disorder (Autism) 01/2022 - 08/2015
6	Ischemia 10/2019 - 07/2011
5	Inflammation (Inflammations) 01/2022 - 05/2013
5	Brain Ischemia (Cerebral Ischemia) 10/2019 - 07/2011
4	Hypertrophy 01/2021 - 01/2017
4	Reperfusion Injury 02/2017 - 07/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
3	Neoplasms (Cancer) 01/2021 - 01/2016
3	Fibrosis (Cirrhosis) 01/2018 - 06/2012
3	Vascular Remodeling 01/2017 - 01/2014
3	Tremor (Tremors) 11/2015 - 11/2011
3	Epilepsy (Aura) 08/2014 - 11/2011
2	Neuroinflammatory Diseases 01/2022 - 03/2017
2	Pulmonary Arterial Hypertension 06/2018 - 05/2013
2	Cognitive Dysfunction 01/2017 - 08/2014
2	Gliosis 01/2012 - 11/2011
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Ischemic Stroke 10/2019
1	Liver Failure 09/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2016
1	Lung Neoplasms (Lung Cancer) 03/2016
1	Right Ventricular Hypertrophy 01/2016
1	Stroke (Strokes) 01/2016
1	Pulmonary Hypertension 01/2016
1	Seizures (Absence Seizure) 11/2015
1	Colonic Neoplasms (Colon Cancer) 09/2015
1	Nervous System Trauma 08/2015
1	Arteritis 05/2013
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 03/2013
1	Alzheimer Disease (Alzheimer's Disease) 03/2013

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2011
8	carvacrolIBA 10/2019 - 01/2014
8	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2019 - 02/2012
6	Neuroprotective AgentsIBA 01/2022 - 07/2011
4	Angiotensin IIIBA 01/2021 - 01/2018
4	Valproic Acid (Depakote)FDA LinkGeneric 01/2018 - 08/2015
3	Small Interfering RNA (siRNA)IBA 03/2022 - 05/2013
3	Competitive Endogenous RNAIBA 01/2022 - 01/2017
3	allicinIBA 05/2019 - 06/2012
3	Cyclin EIBA 06/2018 - 09/2017
2	Long Noncoding RNAIBA 03/2022 - 01/2021
2	Docosahexaenoic AcidsIBA 01/2022 - 04/2016
2	SeleniumIBA 01/2022 - 01/2022
2	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2021 - 12/2018
2	Ruthenium RedIBA 12/2018 - 06/2018
2	Messenger RNA (mRNA)IBA 07/2018 - 01/2017
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2018 - 01/2017
2	EnzymesIBA 01/2018 - 08/2015
2	baicalinIBA 01/2016 - 07/2011
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 11/2015 - 03/2013
2	gamma-Aminobutyric Acid (GABA)IBA 01/2012 - 11/2011
1	Silicon Dioxide (Silica)FDA LinkGeneric 03/2022
1	Sodium SeleniteIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Autophagy-Related Protein-1 HomologIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	IronIBA 10/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	Sirolimus (Rapamycin)FDA Link 05/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	CalciumIBA 12/2018
1	CalcineurinIBA 12/2018
1	transcription factor NF-AT c3IBA 12/2018
1	CationsIBA 12/2018
1	Cyclin DIBA 06/2018
1	Hematoxylin (Haematoxylon)IBA 06/2018
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 06/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2018
1	Cyclin AIBA 06/2018
1	sphingosine kinaseIBA 01/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 03/2017
1	U 0126 (UO 126)IBA 01/2017
1	Prazosin (Minipress)FDA LinkGeneric 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017
1	Ethanol (Ethyl Alcohol)IBA 01/2017
1	Biological ProductsIBA 03/2016
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2016
1	SolutionsIBA 11/2015
1	Protein Kinases (Protein Kinase)IBA 11/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2015
1	baicaleinIBA 08/2014
1	CollagenIBA 01/2014
1	Mitogen-Activated Protein KinasesIBA 01/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2013
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 05/2013
1	Hydroxyeicosatetraenoic Acids (HETE)IBA 05/2013
1	AcidsIBA 05/2013
1	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 05/2013
1	Cell Adhesion MoleculesIBA 05/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2013

Therapy/Procedure

3	Therapeutics 03/2022 - 01/2021
2	Intraperitoneal Injections 03/2017 - 06/2012
1	Liver Transplantation 09/2018